SLC5A2 and diabetes mellitus: Other diabetes medications reported included insulin (41.6%), combination therapy of insulin and other agents (5.7%), sulfonylureas such as Diamicron (1.8%), Glucophage (0.5%), and sodium–glucose cotransporter-2 (SGLT2) inhibitors like Jardiance (0.3%).